881535
Regeneron Pharmaceuticals, Inc. · LSX:881535
851.70 EUR−10.70 −1.24%
Regeneron Pharmaceuticals, Inc. (LSX:881535) last traded at 851.70 EUR, down 1.24% on the day. Over the past year the stock is up 51.55%. Its 52-week range is 508.50 to 865.40. It is in the Health Technology sector (Pharmaceuticals: Major).
Key statistics
Open859.80
Day range851.70 – 859.80
52-week range508.50 – 865.40
Volume34
Average volume (10 days)18
Market cap (USD)99.42 B
P/E21.30
EPS (TTM) (USD)45.30
Dividend yield0.38%
Beta (1 year)0.0814
Revenue (TTM) (USD)16.90 B
Employees15.41 K
Performance
+17.41%1 week
+30.65%1 month
+29.22%3 months
+39.26%6 months
+29.95%Year to date
+51.55%1 year
Technical reading
Bullish
Daily summary of what 11 oscillators and 15 moving averages show. See every indicator
Latest headlines
- Silicon Valley Promises AI Will Cure Disease. Drugmaker CEOs Aren't Buying It. — WSJDow Jones Newswires · 04 Nov 2026
- How health care is on the ballot in the midtermsSeeking Alpha · 03 Nov 2026
- Regeneron Announces Investor Conference PresentationsGlobeNewswire · 02 Nov 2026
- Regeneron Pharma Price Target Raised to $997.00/Share From $835.00 by Leerink PartnersDow Jones Newswires · 02 Nov 2026
- Regeneron Pharma Price Target Raised to $812.00/Share From $756.00 by BernsteinDow Jones Newswires · 02 Nov 2026
- Regeneron Pharma Price Target Raised to $855.00/Share From $779.00 by Morgan StanleyDow Jones Newswires · 02 Nov 2026
- Regeneron Pharma Price Target Raised to $913.00/Share From $810.00 by RBC CapitalDow Jones Newswires · 02 Nov 2026
- Regeneron Pharma Price Target Raised to $982.00/Share From $780.00 by Truist SecuritiesDow Jones Newswires · 02 Nov 2026
Market data is delayed as each exchange requires (see data coverage). SuperCharting is charting software and gives no investment advice.